LENZ Therapeutics (LENZ) Leases: 2022-2023
Historic Leases for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $13.2 million.
- Therapeutics' Leases rose 85.32% to $13.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $13.2 million, marking a year-over-year increase of 85.32%. This contributed to the annual value of $5.6 million for FY2022, which is N/A change from last year.
- Latest data reveals that Therapeutics reported Leases of $13.2 million as of Q3 2023, which was down 16.68% from $15.8 million recorded in Q2 2023.
- Therapeutics' Leases' 5-year high stood at $15.8 million during Q2 2023, with a 5-year trough of $4.0 million in Q1 2023.
- Over the past 2 years, Therapeutics' median Leases value was $8.6 million (recorded in 2022), while the average stood at $9.2 million.
- Examining YoY changes over the last 5 years, Therapeutics' Leases showed a top increase of 85.32% in 2023 and a maximum decrease of 60.34% in 2023.
- Quarterly analysis of 2 years shows Therapeutics' Leases stood at $5.6 million in 2022, then soared by 85.32% to $13.2 million in 2023.
- Its Leases was $13.2 million in Q3 2023, compared to $15.8 million in Q2 2023 and $4.0 million in Q1 2023.